| Literature DB >> 29704306 |
David Owen1, Ana Töpf1, Veeramani Preethish-Kumar2, Paulo José Lorenzoni3, Bas Vroling4, Rosana Herminia Scola3, Elza Dias-Tosta5, Argemiro Geraldo6, Kiran Polavarapu2, Saraswati Nashi2, Daniel Cox1, Teresinha Evangelista1, John Dawson1, Rachel Thompson1, Jan Senderek7, Steven Laurie8,9, Sergi Beltran8,9, Marta Gut8,9, Ivo Gut8,9, Atchayaram Nalini2, Hanns Lochmüller1,8,10.
Abstract
Congenital myasthenic syndrome (CMS) is a heterogeneous disorder that causes fatigable muscle weakness. CMS has been associated with variants in the MuSK gene and, to date, 16 patients have been reported. MuSK-CMS patients present a different phenotypic pattern of limb girdle weakness. Here, we describe four additional patients and discuss the phenotypic and clinical relationship with those previously reported. Two novel damaging missense variants are described: c.1742T > A; p.I581N found in homozygosis, and c.1634T > C; p.L545P found in compound heterozygosis with p.R166*. The reported patients had predominant limb girdle weakness with symptom onset at 12, 17, 18, and 30 years of age, and the majority exhibited a good clinical response to Salbutamol therapy, but not to esterase inhibitors. Meta-analysis including previously reported variants revealed an increased likelihood of a severe, respiratory phenotype with null alleles. Missense variants exclusively affecting the kinase domain, but not the catalytic site, are associated with late onset. These data refine the phenotype associated with MuSK-related CMS.Entities:
Keywords: congenital myasthenic syndrome; late onset; limb girdle; muscle-specific kinase
Mesh:
Substances:
Year: 2018 PMID: 29704306 DOI: 10.1002/ajmg.a.38707
Source DB: PubMed Journal: Am J Med Genet A ISSN: 1552-4825 Impact factor: 2.802